Examination of the Evidence for Off-Label Use of Gabapentin

OBJECTIVES: (1) Describe the relevance of off-label use of gabapentin to managed care pharmacy; (2) summarize recent FDA warnings and media reports related to off-label gabapentin use; (3) review medical information pertaining to the off-label use of gabapentin; (4) outline alternatives to off-label...

Descripción completa

Detalles Bibliográficos
Autor principal: Mack, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Contemporary Subjects
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437292/
https://www.ncbi.nlm.nih.gov/pubmed/14664664
http://dx.doi.org/10.18553/jmcp.2003.9.6.559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437292/
https://www.ncbi.nlm.nih.gov/pubmed/14664664
http://dx.doi.org/10.18553/jmcp.2003.9.6.559

Ejemplares similares